Robert "Mike" Brock is a nationally recognized trial lawyer with 25 years of experience handling high-stakes, bet-the-business litigation. His practice focuses on representing pharmaceuticals and life sciences companies, particularly in product liability and mass tort cases. He has tried cases in a wide range of areas and has represented clients in antitrust, malpractice, toxic tort and securities class action litigation, as well as in other types of cases. Mike is a fellow of the American College of Trial Lawyers.
Mike has represented companies in some of the most high-stakes litigation in recent history. He currently serves as lead trial lawyer for BP in the Deepwater Horizon oil spill litigation. His trial performance has been highly praised and widely reported in the press. According to the Financial Times, one legal professional said that "in a courtroom full of top-tier legal talent," Mike was particularly impressive, delivering "one of the most methodical and skillful cross-examinations I have seen" in 25 years.
Mike has also been exceptionally successful in his representations of leading pharmaceutical companies in product liability cases. He secured jury verdicts for Merck in a Fosamax® case in New York City and for AstraZeneca in its first Seroquel® lawsuit in New Brunswick, NJ. He also served as lead trial counsel to Merck in several Vioxx® cases, securing wins in Alabama, California, Florida and New Jersey. Recently, he has served as lead trial counsel for Pfizer in its Chantix® litigation and for Boehringer Ingelheim in litigation concerning Pradaxa®.
Mike is recognized by various legal publications as a first-class trial lawyer in products liability and mass tort litigation. He has been selected as a “leading lawyer” by Chambers USA, America's Leading Lawyers for Business every year since 2009 and the current edition describes him as “a seasoned trial lawyer who boasts impressive experience representing a range of defendants in high-stakes product liability trials.” Sources for the guide say he is “one of the elite trial lawyers in the U.S.” with a “great courtroom presence” and an ability to “take complex issues and break them down in a way that’s accessible and understandable” and is “a first-rate first-chair trial lawyer” who “is front and center” in major disputes. He was also listed in the 2015–2018 editions of Chambers Global, The World's Leading Lawyers for Business. In 2014 and 2015, The Legal 500 U.S. selected Mike as a “leading lawyer” for Product Liability & Mass Tort Defense: Pharmaceuticals and Medical Devices, a distinction given to only 14 lawyers nationwide, and singled him out as a “renowned trial lawyer.” He is also recognized by Legal 500 for Energy: Litigation and by Benchmark Litigation as a “National Star.”
Prior to joining Kirkland, Mike was a partner at Covington & Burling LLP, where he was the chair of their product liability and mass torts practice.
Chambers USA, Product Liability (2009–2018) and Litigation: Trial Lawyers (2014–2018)
The Legal 500 U.S.,"Leading Lawyer," Product Liability & Mass Tort Defense: Pharmaceuticals and Medical Devices (2014)
The Legal 500 U.S., Product Liability & Mass Tort Defense: Pharmaceuticals and Medical Devices (2012–2014); Energy: Litigation (2014)
Benchmark Litigation, National Star (2013–2014)
Washington DC Super Lawyers, Products: Defense (2011–2016)
The Best Lawyers in America, Product Liability Litigation - Defendants (2013–2019)
LMG Life Sciences Awards, shortlisted for Product Liability Attorney of the Year (2013)
LMG Life Sciences, "Life Science Star" (2013)
The Practical Law Company (PLC), Products Liability (2012)
Memberships & Affiliations
Fellow, American College of Trial Lawyers
Member, American Board of Trial Advocates (ABOTA)
Admissions & Qualifications
- 2010District of Columbia
- The University of Alabama School of LawJ.D.1984
- The University of AlabamaB.S., Business and Commerce1981All Southeastern Conference Offensive Lineman